Press release
United States Metered-Dose Inhalers Market (2025-2033) | COPD, Digital Inhalers, Smart Respiratory Devices, Next-Generation Inhaler Systems & Market Opportunities
Metered-Dose Inhalers Market Size 2025
Get Latest Sample Report Analysis 2026 (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/metered-dose-inhalers-market?kb
United States: Recent Industry Developments
✅ March 2026: GlaxoSmithKline plc (GSK) expanded manufacturing capabilities for next-generation metered-dose inhalers supporting respiratory care demand across the U.S.
✅ February 2026: AstraZeneca PLC strengthened investment in low-carbon propellant inhaler technologies to align with evolving environmental sustainability goals.
✅ January 2026: Viatris Inc. advanced development of generic metered-dose inhalers focused on improving affordability and patient accessibility in asthma treatment.
✅ December 2025: Teva Pharmaceutical Industries Ltd. enhanced production capacity for respiratory inhalation products targeting chronic obstructive pulmonary disease (COPD) therapies.
Ready to scale in the Metered-Dose Inhalers Market? Strengthen your strategic positioning by connecting with the right ecosystem partners and accessing trusted data-driven opportunities today:- https://www.datamintelligence.com/partner-identification-enquiry/metered-dose-inhalers-market?kb
List of Key Players 2026:
AstraZeneca, GlaxoSmithKline, Boehringer Ingelheim, Teva Pharmaceuticals, Cipla Ltd, and Sunovion Pharmaceutical
Key Growth Forecast Projection 2026:
The Global Metered-Dose Inhalers Market is projected to register a significant growth trajectory over the forecast period 2026-2033. In 2025, the market continues to demonstrate steady expansion, supported by increasing adoption of strategic initiatives by leading industry participants. Strengthened by evolving demand patterns, technological advancements, and credible industry insights, the outlook reflects sustained momentum across the forecast horizon.
Key Strategic Developments 2025-2026:
✅ April 2026: GlaxoSmithKline plc expanded development of next-generation low-carbon metered-dose inhalers using sustainable propellant technologies to support respiratory care and environmental compliance initiatives.
✅ March 2026: AstraZeneca plc strengthened manufacturing capabilities for metered-dose inhalers to improve supply reliability and support increasing respiratory disease treatment requirements globally.
✅ January 2026: Boehringer Ingelheim International GmbH increased investment in propellant transition programs focused on reducing greenhouse gas emissions from respiratory inhalation therapies.
✅ December 2025: Teva Pharmaceutical Industries Ltd. enhanced digital inhaler technologies with integrated dose monitoring and patient adherence features for improved respiratory disease management.
✅ November 2025: Cipla Limited expanded production of affordable metered-dose inhalers targeting asthma and chronic obstructive pulmonary disease treatment accessibility across emerging markets.
✅ October 2025: Chiesi Farmaceutici S.p.A. accelerated commercialization of carbon-minimal inhaler platforms developed with next-generation environmentally sustainable propellants.
How Our Market Research Process Works:
The global Metered-Dose Inhalers Market research report is developed through a primary and secondary intelligence sources to ensure high data reliability and industry relevance. The study examines a broad set of market-shaping variables, including regulatory frameworks, shifting demand patterns, competitive landscape intensity, and long-term historical performance indicators. In addition, the report provides a structured assessment of market fluctuations, expansion opportunities, entry barriers, and critical challenges that may influence the future growth trajectory of the Metered-Dose Inhalers market landscape.
Funding/M&A/partnerships 2025-2026:
• April 2026: Chiesi Group agreed to acquire KalVista Pharmaceuticals to strengthen its respiratory and rare disease inhalation portfolio expansion.
• February 2026: Danaher Corporation announced the acquisition of Masimo Corporation, expanding respiratory monitoring and inhalation-related healthcare technologies.
• January 2026: Chongqing Pharmaceutical Holding Group backed inhalation drug developer Runsheng Pharma following U.S. FDA approval of its inhalation therapy platform products.
Unlock 360° Best Strategic Growth Report: https://www.datamintelligence.com/buy-now-page?report=metered-dose-inhalers-market?kb
Japan: Recent Industry Developments
✅ March 2026: Kyorin Pharmaceutical Co., Ltd. expanded respiratory product development initiatives for metered-dose inhalers addressing increasing pulmonary care requirements.
✅ February 2026: Otsuka Pharmaceutical Co., Ltd. strengthened partnerships focused on advanced inhalation drug delivery technologies for chronic respiratory diseases.
✅ January 2026: Takeda Pharmaceutical Company Limited accelerated research activities related to innovative inhalation therapies and precision respiratory medicine.
✅ December 2025: Daiichi Sankyo Company, Limited supported expansion of pulmonary drug formulation capabilities for next-generation inhalation treatment platforms.
Major Segments Opportunity 2026:
By Product Type: Breath-Actuated Pressurized Inhalers, Manually-Actuated Pressurized Inhalers, Soft Mist Inhalers
By Application: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Others)
By End User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Regional Growth Trajections for Market:
⇥ North America - Leads the Metered-Dose Inhalers market due to the high prevalence of asthma and COPD along with strong access to respiratory care treatments.
⇥ Europe - Growth is supported by increasing adoption of advanced inhalation therapies and expanding healthcare reimbursement systems.
⇥ Asia-Pacific - Fastest-growing region driven by rising respiratory disease cases, urban pollution, and improving healthcare infrastructure.
⇥ Latin America - Market expansion is fueled by growing awareness of respiratory health and increasing availability of inhalation therapies.
⇥ Middle East & Africa - Emerging demand supported by improving healthcare access and rising diagnosis rates of chronic respiratory disorders.
Request Strategic Market Customization: https://datamintelligence.com/customize/metered-dose-inhalers-market?kb
Market Drivers 2026:
Increasing prevalence of asthma, COPD, and other chronic respiratory disorders is supporting long-term utilization of metered-dose inhalers across healthcare systems.
Expansion of generic inhaler manufacturing and broader availability of cost-effective respiratory therapies are strengthening product accessibility in emerging markets.
Continuous preference for portable, quick-administration respiratory drug delivery devices is sustaining adoption of metered-dose inhalers in homecare and emergency treatment settings.
Technological improvements in dose counters, breath-actuated inhalers, and propellant formulations are enhancing treatment accuracy and patient compliance.
Growth in urban air pollution exposure and smoking-related respiratory complications is contributing to higher prescription volumes for inhalation therapies.
Regulatory transition toward low global warming potential propellants is encouraging product reformulation and next-generation inhaler development activities.
Increasing inclusion of inhalation therapies in public healthcare reimbursement programs is supporting wider patient access to respiratory medications.
FAQ's 2026:
Q1: What is the current size of the Metered-Dose Inhalers Market?
A: The Metered-Dose Inhalers Market was valued at US$16.6 billion in 2023 and is projected to reach US$24.18 billion by 2033, reflecting steady expansion supported by evolving industry demand, data-driven adoption trends, and ongoing investment.
Q2: How rapidly is the Market expanding?
A: The Metered-Dose Inhalers Market is expected to grow at a CAGR of 4.8% during the forecast period 2025 to 2033, growth by increasing commercialization, and strengthening application scope across key sectors.
Get Unlimited Market Reports & Strategic Insights: https://www.datamintelligence.com/reports-subscription?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Metered-Dose Inhalers Market (2025-2033) | COPD, Digital Inhalers, Smart Respiratory Devices, Next-Generation Inhaler Systems & Market Opportunities here
News-ID: 4514612 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Recycled Plastic Market Set for Robust Growth to US$ 95.5 Billion by 2031 Amid E …
DataM Intelligence has released a new research report titled "Recycled Plastic Market Size 2026". The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms…
Future of Sericulture Market (2033) | Silk Production, Textile Exports, Silk Yar …
DataM Intelligence has released its latest research report, "Sericulture Market Size 2026", offering a structured and data-driven assessment of evolving market dynamics and long-term growth potential. The study delivers detailed insights into market sizing, revenue trajectories, CAGR outlook, and regional performance trends, supported by robust segmentation analysis across key industry verticals. The report also highlights emerging growth pockets, investment-aligned opportunities, and areas where innovation and strategic expansion are reshaping industry…
Silicon Carbide (SiC) Semiconductor Market to Reach USD 3,058.00 Million by 2033 …
The global Silicon Carbide (SiC) semiconductor market was valued at USD 939.00 million in 2025 and is projected to reach nearly USD 3,058.00 million by 2033, growing at a CAGR of 15.9% during the forecast period from 2026 to 2033, according to a DataM Intelligence report. The market is witnessing strong growth driven by the increasing demand for energy efficient power electronics, rapid adoption of electric vehicles (EVs), and expanding…
3D Printing in Construction Market to Witness Explosive Growth as Automation Tra …
DataM Intelligence has released a new research report titled "3D Printing In Construction Market Size 2026". The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size…
More Releases for Inhalers
North America Leads the Surge in Metered-Dose Inhalers Market Adoption | Metered …
The Global Metered-Dose inhalers Market reached US$ 16.6 billion in 2023 and is expected to reach US$ 24.18 billion by 2033, growing at a CAGR of 4.8% during the forecast period 2025-2033.
The Metered-Dose Inhalers (MDI) Market focuses on drug delivery devices used in managing respiratory disorders like asthma and COPD. MDIs provide precise, portable, and fast-acting medication administration. The market is expanding due to growing respiratory disease incidence and environmental…
Inhalers Market Analysis-Growth Projections
The Inhalers Market is expected to register a CAGR of 5.3% from 2025 to 2031
Download PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00021658?utm_source=OpenPR&utm_medium=10392
Market leaders and key company profiles
3M
Agilent Technologies
GlaxoSmithKline
Novartis
Propeller Health
Boehringer Ingelheim
BESPAK
AstraZeneca
Cohero Health
Segments Covered By Devices
Metered Dose Inhalers
Dry Powder Inhalers
Nebulizers
Nasal Inhalers
By Type
Preventive Inhalers
Reliever Inhalers
Long-Acting Bronchodilators Inhalers
By Application
Asthma
Chronic Obstructive Pulmonary Diseases
Others
By End User
Home Care
Hospitals and Clinics
Others
Contact Us:
Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help…
Inhalers Market Size 2024 to 2031.
Market Overview and Report Coverage
The Inhalers Market refers to the pharmaceutical devices used for delivering medications directly into the lungs, thereby providing quick relief for respiratory conditions such as asthma and COPD. The market is expected to witness substantial growth over the forecasted period, with a projected CAGR of 9.30%.
Several factors are driving this growth, including the increasing prevalence of respiratory diseases worldwide, rising awareness about the…
Dry Powder Inhalers Market - Breathe Freely: Dry Powder Inhalers Empowering Asth …
Newark, New Castle, USA: The "Dry Powder Inhalers Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Dry Powder Inhalers Market: https://www.growthplusreports.com/report/dry-powder-inhalers-market/8762
This latest report researches the industry structure,…
Smart Inhalers Market Boosting The Growth Worldwide
Precision Business Insights published a research report on “Smart Inhalers Market By Product Type (Inhalers, Metered dose inhalers, Dry powder inhalers, Nebulizers), By Application (COPD and Asthma), By Distribution channel (Hospitals, Retail pharmacies and Online pharmacies) - Global/Region/Country Forecast to 2028”.
Smart inhalers, also known as connected inhalers and sensors, are typically used as clip-on sensors on top of a normal nebulizer for the medication of COPD and asthma.…
Smart Inhaler Market - Industry Analysis, Size, Share, Growth, Trends, and Forec …
The Smart Inhaler Market is projected to gain market revenue of US$ 4,563.1 million by 2026, growing at a CAGR of 15.72% during the forecast period 2020-2026. Owing to the rising adoption of Smart Inhaler services due to the rapid increase in the aging population along with respiratory disorders associated with them. Moreover, increasing incidence of respiratory diseases, the rise in air pollution, and growth in healthcare burden owing to…
